ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,847Medicare Part D Prescriptions Filled, Including Refills
$581K Total Retail Price of All Prescriptions
349 Patients Receiving at Least One Drug in Part D
96%Patients 65 Years and Older
31% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
NAMENDA 826 796
DONEPEZIL HCL 609 586
LEVOTHYROXINE SODIUM 406 402
MIRTAZAPINE 400 388
FUROSEMIDE 335 333
CITALOPRAM HBR 334 321
WARFARIN SODIUM 328 327
LISINOPRIL 258 245
OMEPRAZOLE 253 241
SIMVASTATIN 235 231
HYDROCODONE-ACETAMINOPHEN 216 189 S3
AMLODIPINE BESYLATE 216 216
POTASSIUM CHLORIDE 212 212
SERTRALINE HCL 206 191
METOPROLOL TARTRATE 188 188
TRAMADOL HCL 177 177
EXELON 139 138
RISPERIDONE 129 129
FENTANYL 114 114 S2
ATORVASTATIN CALCIUM 106 106
ATENOLOL 98 98
METOPROLOL SUCCINATE 97 91
METFORMIN HCL 95 75
QUETIAPINE FUMARATE 93 68
ESCITALOPRAM OXALATE 92 92
HYDROCHLOROTHIAZIDE 91 91
DIVALPROEX SODIUM 77 77
ARICEPT 77 77
GABAPENTIN 75 73
POLYETHYLENE GLYCOL 3350 73 73
PREDNISONE 70 61
CLOPIDOGREL 68 68
NYSTOP 59 59
KLOR-CON M20 59 59
BUPROPION XL 55 49
DIGOXIN 53 53
OXYBUTYNIN CHLORIDE ER 51 47
TRAZODONE HCL 51 29
LATANOPROST 50 50
CARVEDILOL 50 50
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 5, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.